Personalis Ripon College Days / Apr 25, 2022
Want to see the real deal?
More inside scoop? View in App
More inside scoop? View in App
FOLLOWING
Show more
Personalis News
Personalis Defense World / Apr 24, 2022
Research Analysts’ upgrades for Saturday, April 23rd: ASE Technology (NYSE:ASX) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Big 5 Sporting Goods (NASDAQ:BGFV) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. LiqTech International (NASDAQ…
Defense World
Personalis Benzinga / Apr 22, 2022
Georgetown has joined a global partnership to help foster the well-being of individuals working in social change and education.
Benzinga
Personalis Benzinga / Apr 22, 2022
On Friday =, 431 companies hit new 52-week lows.
Benzinga
Personalis Thursday, April 21st, 2022 / Apr 21, 2022
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the appointment of James Azzaro to the newly cr
Personalis Thursday, April 21st, 2022 / Apr 21, 2022
Here’s a look at what the ARK Invest exchange-traded funds bought on April 20, 2022.
Cathie Wood’s ARK Invest Buys for 4/20
Thursday, April 21st, 2022
Personalis Thursday, April 21st, 2022 / Apr 21, 2022
By Marty Dubecky, Staff Writer Dr. Nezan Al-Nsair will be appointed dean of the College of Nursing after an almost three-year period during which the position has been held by Interim Dean Dr. Judi…
XU names Al-Nsair nursing dean
Thursday, April 21st, 2022
Personalis Precision Oncology News / May 8, 2021
The data, while limited, indicate that the firm’s blood-only assay may be able to match the performance of existing commercial tissue-informed competitors.
Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape
Precision Oncology News
Personalis Business Wire / May 5, 2021
MENLO PARK, Calif.--()--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today reported financial results for the first quarter ended March 31, 2021.
Personalis Reports First Quarter 2021 Financial Results
Business Wire
Personalis Yahoo Finance / May 5, 2021
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / Personalis Inc (NASDAQ:PSNL) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 5:00 PM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.
Personalis Inc to Host Earnings Call
Yahoo Finance
Personalis CML News / May 5, 2021
Published: 05/05/2021 20:48 GMT Personalis Inc (PSNL) - Personalis Reports First Quarter 2021 Financial Results.Q1 Loss per Share $0.29.Sees Q2 Revenue About $21.3 Million.Sees FY Revenue About $85 Million.Q1 Revenue Rose 9 Percent to $20.9 Million.Q1 Revenue View $20.4 Million -- Refinitiv Ibes Data (analyst estimates).FY2021 Revenue View $84.7 Million -- Refinitiv Ibes Data (analyst estimates).
CML News
Personalis Zacks.com / May 5, 2021
Personalis ( - Free Report) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 21.62%.
Zacks.com
Personalis WFMZ Allentown / May 5, 2021
DUBLIN, May 5, 2021 /PRNewswire/ -- The "Molecular Diagnostics for Cancer 2021-2025: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization" report has been added to ResearchAndMarkets.com's offering. A market with fundamental growth factors is impacted by the COVID-19 Pandemic.
Personalis Yahoo Finance / May 5, 2021
Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the first quarter of 2021 and issued guidance for its second quarter and full year of 2021. First Quarter 2021 Financial Highlights Total revenue was $74.0 million, an increase of 9% from $68.0 million in the first quarter of 2020.
Personalis Yahoo Finance / May 5, 2021
According to Coherent Market Insights, the global CRISPR and CAS gene market is estimated to be valued at US$ 830.7 million in 2020 and is expected to exhibit a CAGR of 22.8% during the forecast period (2020-2027).
Personalis Yahoo Finance / May 5, 2021
Global network of 45 partners driving diversity within boards and executive teams Diligent Corporation, the global leader in SaaS governance, risk and compliance, today announced the addition of four new women's leadership partners - Catalyst, The Fourth Floor, Kellogg School of Management Center for Executive Women, and Women2Boards - in its growing Modern Leadership initiative which was created to further increase diverse representation at the executive and board levels for global businesses.
Personalis Yahoo Finance / May 5, 2021
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported financial results for the first quarter of 2021, and provided updates on its strong ophthalmology pipeline.
Personalis Yahoo Finance / May 5, 2021
More than eight in ten consumers (86%) say that their payments habits have changed since the start of the pandemic, with 59% trying a new payment method for the first time - a number which rises to 77% among the 18- to 24-year-old age group.
Personalis The Spokesman-Review / May 4, 2021
As constituents of Washington state, we are writing to ask for your promotion and publicity of implementing a Mental Health Awareness week in K-12 schools in the month of May as proposed by The National Alliance on Mental Health (NAMI).
Personalis KSU | The Sentinel Newspaper / May 4, 2021
KSU | The Sentinel Newspaper